King's College London

Research portal

Psychosis Clinical Academic Group

Organisational unit: Clinical Academic Group

Contact information

  • Phone: 0207 848 0355

Organisation profile




The largest group of psychosis expert clinicians and researchers in the world, the Clinical Academic Group brings together academic and clinical staff working across King’s College London and South London and Maudsley. As the largest mental health CAG, we provide treatment for 10,000 people and have 1,300 staff in 74 teams across the boroughs of Lambeth, Lewisham, Southwark and Croydon, as well as offering national services for patients who are resistant to treatment. Our annual budget is £100million across health and social care. The CAG is the first organisation in the world to develop clinical services for psychosis based on care pathways that are specialised for each stage of psychotic illness: Early Intervention, Acute, Promoting Recovery and Complex Care. The pathway model is currently being evaluated and initial results will be available shortly.

The CAG is a world leader in psychosis research, and its clinical services provide an unrivalled platform for a programme of major studies supported by Medical Research Council (MRC), National Institute for Health Research, Wellcome Trust, European Union, and by industry (Roche, Lundbeck, Lilly, Amgen, Abbott). Since its inception, the CAG has already approved over 100 new research studies in psychosis. The CAG has particular expertise in research on the early phase of psychosis, the neurobiological basis of psychosis, the role of cannabis use in psychosis, treatment resistance in psychosis, and the use of psychological and cognitive treatments in psychosis.

The CAG has also been highly innovative in education and training, with a strategic focus on developing new training that is specific to psychosis. New courses that provide psychosis-specific training for administrative staff and support workers have been developed and are currently undergoing evaluation, and a new MSc in Early Intervention for Psychosis will start enrolling students in autumn 2013.


Particular achievements of the CAG since its inception have been:

• identification of the neurochemical basis of treatment resistance in psychosis;

• being selected as a national demonstration site for psychosis for the Department of Health’s IAPT-SMI programme;

• development of the care pathway model that has since been adopted at other centres


Clinical Academic Group Leads:

Philippa Garety

Philip McGuire

Godfried Attatua


Psychosis Outcome Book

Launched in  2014/2015, the outcome book provides an amalgamation of the collective clinical, eduction and research outcomes of the group detailing its achievements, ambitions and the opportunites for growth.  

Top downloads

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454